Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buscopan vs Anisodamine for Acute Gastric or Intestinal Spasm-like Pain
NCT01929044Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hyoscine butylbromide in gastrointestinal spasm, sponsored by Boehringer Ingelheim. Started Aug 2013; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
gastrointestinal spasm
Beyond the preview
Go deeper on NCT01929044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01929044.